AKT1 and Sepsis: Combined with the results of network pharmacology analysis, it was illustrated that inhibiting the PI3K/AKT signaling pathway could activate apoptosis in sepsis, while RDN may activate this pathway by targeting AKT1, thus improving apoptosis and slowing down endothelial cell injury.